MedTrace Logo

Clinical Study on Rapid Antioxidant Protection and Immune Modulating Effects.

NCT05042674 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2022-06-09

No results posted yet for this study

Summary

A trial on acute antioxidant protection and immune effects when 24 people consume a novel nutraceutical blend compared to a placebo on different test days.

Conditions

  • Pharmacokinetics

Interventions

DIETARY_SUPPLEMENT

Placebo

after a blood draw placebo will be consumed followed by 2 additional blood draws

DIETARY_SUPPLEMENT

Ergothioneine, 25 miligrams

after a blood draw 25 miligrams of ergothioneine will be consumed followed be 2 additional blood draws

DIETARY_SUPPLEMENT

Ergothioneine, 25 miligrams, daily for 1 week

a blood draw will be administered after a week of consuming 25mg ergothioneine daily

Sponsors & Collaborators

  • Natural Immune Systems Inc

    lead OTHER

Principal Investigators

  • Gitte Jensen, PhD · NIS Labs

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-20
Primary Completion
2023-03-25
Completion
2023-05-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05042674 on ClinicalTrials.gov